Han Wettenstein

Han has more than 20 years of experience in finance and accounting across life science, data science and technology companies. Han joined Graybug in 2018 as the company’s Controller and has been instrumental in preparing and executing Graybug’s IPO in 2019. Prior to Graybug, she served in several finance and accounting leadership roles at global and divisional levels, including Halio, Inc., a global electrochromic technology company, Bio-Techne Corporation, a leading life sciences and diagnostics technology manufacturer, Ocera Therapeutics (acquired by Mallinckrodt Pharmaceuticals), Amyris, Inc., a sustainable products company, and Symyx Technologies. Han earned her B.S. in business with a concentration in accounting from the University of Phoenix, California.